Acorn Regulatory is pleased to announce the expansion of its EU Medical Device Vigilance Reporting services, helping medical device manufacturers navigate increasingly complex regulatory requirements under the (EU MDR 2017/745).

Regulatory affairs consultancy services play a vital role in guiding pharmaceutical companies through every stage of the product lifecycle, from early-stage development and clinical trials to marketing authorization and post-market surveillance.